Stocks · Healthcare · Medical - Devices
Insulet Corp. PODD
$131.69 +0.69% Close, Oct 2, 2026 · NASDAQ · Market cap $9.12B
High qualityWeak trendInexpensive vs sector
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $5.35, up 62.6% year over year.
- At 24.6× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Earnings beat analyst estimates in each of the last 8 quarters (average surprise over the last four: +11.6%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 25%
- EPS growth (TTM, YoY)Top 22%
- FCF growth (TTM, YoY)Bottom 23%
- Revenue growth, 3-year CAGRTop 24%
- Revenue growth accelerationBottom 34%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 7%
- Gross marginTop 41%
- Operating marginTop 16%
- Cash conversion (OCF / net income)Bottom 39%
- Accruals (lower is better)Bottom 38%
- Net debt / EBITDA (lower is better)Top 43%
- Interest coverTop 18%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 13%
- Free-cash-flow yieldTop 25%
- EBITDA / enterprise valueTop 18%
- Sales / enterprise valueTop 41%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 7%
- 6-month returnBottom 12%
- 1-year return vs S&P 500Bottom 7%
- Distance from 52-week highBottom 13%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 35%
- Consecutive EPS beatsTop 8%
- Share of analysts rating BuyBottom 21%
- Upside to consensus price targetBottom 40%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 48%
- Maximum drawdown, 3 yearsTop 40%
- Beta vs S&P 500 (lower is better)Top 10%
- Net debt / EBITDA (lower is better)Top 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 31.9% | 29.4% | ↓ |
| EPS growth (YoY) | -22.7% | 62.6% | ↑ |
| Gross margin | 70.7% | 71.1% | ↑ |
| Operating margin | 17.3% | 16.9% | ↓ |
| FCF margin | 16.5% | 9.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 29.4% | 31.9% | ↓ | Top 25% |
| EPS growth (TTM, YoY) | 62.6% | -22.7% | ↑ | Top 22% |
| Gross margin | 71.1% | 70.7% | ↑ | Top 41% |
| Operating margin | 16.9% | 17.3% | ↓ | Top 16% |
| Net margin | 12.3% | 10.0% | ↑ | — |
| Free-cash-flow margin | 9.8% | 16.5% | ↓ | — |
| Return on invested capital | 16.0% | — | Top 7% | |
| Revenue growth, 3-year CAGR | 27.5% | — | Top 24% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.36×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +3.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.65×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 8.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 3.50%
- Shareholder yield
- 3.50%
- Share count change, 1 year
- -1.8%
- Share count change, 3-year CAGR
- -0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 8
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +11.6%
- Average 2-day reaction, last 8
- -1.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $185.18
- Target vs current price
- +40.6%
- Analysts with a rating
- 50
- Share rating Buy or Strong Buy
- 56%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +12.9% | -20.1% | -13.3% | -11.1% | — |
| May 6, 2026 | +19.3% | -9.7% | -5.5% | -14.5% | -1.3% |
| Feb 18, 2026 | +5.4% | +4.8% | -0.4% | -6.4% | -39.6% |
| Nov 6, 2025 | +8.8% | +2.8% | +7.1% | +0.5% | -20.1% |
| Aug 7, 2025 | +27.2% | +9.5% | +11.3% | +24.9% | +12.5% |
| May 8, 2025 | +29.1% | -2.8% | +21.6% | +20.0% | +8.9% |
| Feb 20, 2025 | +15.0% | +1.6% | -4.6% | -6.3% | +13.5% |
| Nov 7, 2024 | +18.4% | +2.4% | +12.4% | +11.8% | +19.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $1.66 | $1.47 | +12.9% | $801.7M |
| May 6, 2026 | $1.42 | $1.19 | +19.3% | $761.7M |
| Feb 18, 2026 | $1.55 | $1.47 | +5.4% | $783.8M |
| Nov 6, 2025 | $1.24 | $1.14 | +8.8% | $706.3M |
| Aug 7, 2025 | $1.17 | $0.92 | +27.2% | $649.1M |
| May 8, 2025 | $1.02 | $0.79 | +29.1% | $569.0M |
| Feb 20, 2025 | $1.15 | $1.00 | +15.0% | $597.5M |
| Nov 7, 2024 | $0.90 | $0.76 | +18.4% | $372.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 24.6× | 92.3× | 0th | Top 13% |
| P/E (forward) | 20.3× | — | — | — |
| EV / EBITDA | 15.0× | — | — | Top 18% |
| EV / Sales | 3.12× | — | — | Top 41% |
| Free-cash-flow yield | 3.27% | — | — | Top 25% |
| Earnings yield | 4.06% | — | — | Top 13% |
P/E over the past five years
Range 24.9× – 326.3× since Mar 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -57.0%
- Earnings per share growth (TTM)
- +62.6%
- Change in P/E multiple
- -73.0%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.0%
- 200-day average slope (20 days)
- -8.4%
- Distance from 50-day average
- -9.3%
- Distance from 200-day average
- -31.9%
- RSI (14)
- 35.8
- Relative volume
- 1.88×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 56.3%
- Volatility vs own 5-year history
- 81th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.34
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -62.0%
- Maximum drawdown, 3 years
- -63.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 9, 2025 | Sep 30, 2026 | -63.0% | 266 days | Not yet recovered |
| May 12, 2023 | Oct 12, 2023 | -61.3% | 105 days | 464 days (Aug 20, 2025) |
| Nov 9, 2021 | May 11, 2022 | -41.4% | 126 days | 214 days (Mar 20, 2023) |
| Apr 27, 2021 | May 12, 2021 | -25.8% | 11 days | 81 days (Sep 7, 2021) |
| Jan 20, 2021 | Mar 8, 2021 | -19.5% | 32 days | 27 days (Apr 15, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $9.12B
- P/E (TTM)
- 24.6
- EPS, diluted (TTM)
- $5.35
- Revenue (TTM)
- $3.05B
- 52-week range
- $126.40 – $354.88
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.10B | $1.31B | $1.70B | $2.07B | $2.71B |
| Gross profit | $752.1M | $805.6M | $1.16B | $1.45B | $1.94B |
| Operating income | $126.0M | $37.6M | $220.0M | $308.9M | $473.8M |
| Net income | $16.8M | $4.6M | $206.3M | $418.3M | $247.1M |
| EPS (diluted) | $0.25 | $0.07 | $2.94 | $5.78 | $3.48 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $543.9M | $597.5M | $569.0M | $649.1M | $706.3M | $783.8M | $761.7M | $801.7M |
| Net income | $77.5M | $100.7M | $35.4M | $22.5M | $87.6M | $101.6M | $91.1M | $95.0M |
| EPS (diluted) | $1.08 | $1.39 | $0.50 | $0.32 | $1.24 | $1.44 | $1.30 | $1.37 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$68.1M | $119.0M | $145.7M | $430.3M | $569.3M |
| Capital expenditure | -$122.7M | -$157.3M | -$75.6M | -$124.9M | -$191.6M |
| Free cash flow | -$190.8M | -$38.3M | $70.1M | $305.4M | $377.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $23.5M | $16.3M | $26.9M | $20.1M | -$25.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $534.9M
- Total assets
- $3.17B
- Total liabilities
- $1.74B
- Total debt
- $948.4M
- Net debt
- $413.5M
- Shareholders’ equity
- $1.42B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 5,082,203
- Days to cover
- 3.15
- Change vs previous report
- +14.3%
FINRA short interest, settlement date Sep 15, 2026.